Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".

Wang, Yijin; Lu, Fengmin; Zhao, Jingmin

Wang, Yijin; Lu, Fengmin; Zhao, Jingmin.

Wang Y; Department of Pathology and Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Lu F; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Zhao J; Department of Pathology and Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, China. Electronic address: jmzhao302@163.com.

J Hepatol ; 73(4): 996-998, 2020 10.

Article in English | MEDLINE | ID: covidwho-716808

Subject(s)

Betacoronavirus; Coronavirus Infections; Liver Diseases; Pandemics; Pneumonia, Viral; COVID-19; Humans; Liver/physiopathology; Liver Diseases/virology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Liver Diseases Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: J.jhep.2020.06.028

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google